In Nature this week: machine learning-based method for CRISPR editing, symbiotic genes of Medicago truncatula, and more.
The investigators showed that template-free Cas9 editing is capable of repair to a predicted genotype, allowing for correction of disease-associated mutations.
DefiniGen said it plans to use ERS Genomics' technology to create disease models to support drug discovery for type 2 diabetes and other conditions.
The MIT team found that a previously uncharacterized Cas9 from Streptococcus canis has fewer PAM requirements than the more widely used S. pyogenes Cas9.
In a Nature opinion piece, the University of Michigan's Shobita Parthasarathy argues for the use of the patent system to regulate gene editing.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
Gene editing is expected to give rise to new job opportunities, according to BBC Capital.
Researchers use a CRISPR approach in utero to treat a lethal condition in mice, Stat News reports.
Scientists say that a DARPA project to use bugs to modify plant genes could be viewed as a bioweapon, the Associated Press reports.
New Japanese guidelines would allow for gene editing of human embryos for research purposes, according to Nature News.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.